Patent details

EP4374873 Title: AGENT FOR USE IN TREATING OR PREVENTING OPTHALMOLOGICAL CONDITIONS

Basic Information

Publication number:
EP4374873
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP241646405
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AGENT FOR USE IN TREATING OR PREVENTING OPTHALMOLOGICAL CONDITIONS
French Title of Invention:
AGENT POUR UTILISATION DANS LE TRAITEMENT OU LA PRÉVENTION DES AFFECTIONS OPHTALMOLOGIQUES
German Title of Invention:
MITTEL ZUR BEHANDLUNG ODER PRÄVENTION VON AUGENLEIDEN
SPC Number:

Dates

Filing date:
11/07/2014
Grant date:
22/10/2025
EP Publication Date:
29/05/2024
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/10/2025
EP B1 Publication Date:
22/10/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
11/07/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/10/2025
 
 

Name:
Astellas US LLC
Address:
2375 Waterview Drive, Northbrook IL 60062, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
24/10/2025
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
PATEL, Samir
Address:
United States (US)

Priority

1

Priority Number:
201361845938 P
Priority Date:
12/07/2013
Priority Country:
United States (US)

2

Priority Number:
201361845935 P
Priority Date:
12/07/2013
Priority Country:
United States (US)

3

Priority Number:
201361845936 P
Priority Date:
12/07/2013
Priority Country:
United States (US)

4

Priority Number:
201361866507 P
Priority Date:
15/08/2013
Priority Country:
United States (US)

5

Priority Number:
201361866502 P
Priority Date:
15/08/2013
Priority Country:
United States (US)

6

Priority Number:
201361866503 P
Priority Date:
15/08/2013
Priority Country:
United States (US)

7

Priority Number:
201361911860 P
Priority Date:
04/12/2013
Priority Country:
United States (US)

8

Priority Number:
201361911894 P
Priority Date:
04/12/2013
Priority Country:
United States (US)

9

Priority Number:
201361911854 P
Priority Date:
04/12/2013
Priority Country:
United States (US)

10

Priority Number:
201461926848 P
Priority Date:
13/01/2014
Priority Country:
United States (US)

11

Priority Number:
201461926825 P
Priority Date:
13/01/2014
Priority Country:
United States (US)

12

Priority Number:
201461926812 P
Priority Date:
13/01/2014
Priority Country:
United States (US)

13

Priority Number:
201461931135 P
Priority Date:
24/01/2014
Priority Country:
United States (US)

14

Priority Number:
201461931116 P
Priority Date:
24/01/2014
Priority Country:
United States (US)

15

Priority Number:
201461931125 P
Priority Date:
24/01/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61P 27/02; A61K 39/395; A61K 9/00; A61K 31/713; A61K 45/06; A61P 9/00; A61P 9/10; A61P 25/00; A61P 35/00; A61P 43/00; C07K 16/22; C12N 15/115;

Publication

European Patent Bulletin

Issue number:
202543
Publication date:
22/10/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
22/10/2025 Power Of Attorney 1
24/10/2025 Outgoing Correspondence 1